WCA
TMO icon

Waratah Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Waratah Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,266
Closed -$2.95M – 236
2025
Q2 		$2.95M Buy
7,266
+4,394
+153% +$1.84M 0.08% 124
2025
Q1 		$1.43M Buy
2,872
+5
+0.2% +$2.71K 0.04% 141
2024
Q4 		$1.49M Sell
2,867
-28,686
-91% -$15.8M 0.05% 119
2024
Q3 		$19.5M Sell
31,553
-15,894
-33% -$9.41M 0.38% 43
2024
Q2 		$26.2M Buy
47,447
+18,628
+65% +$10.7M 0.96% 29
2024
Q1 		$16.7M Buy
28,819
+5,622
+24% +$3.15M 0.5% 53
2023
Q4 		$12.3M Buy
23,197
+9,705
+72% +$4.7M 0.24% 56
2023
Q3 		$6.83M Buy
13,492
+9,829
+268% +$5.24M 0.1% 80
2023
Q2 		$1.91M Sell
3,663
-20
-0.5% -$10.8K 0.04% 108
2023
Q1 		$2.12M Hold
3,683
– – 0.05% 119
2022
Q4 		$2.03M Sell
3,683
-14,009
-79% -$7.42M 0.03% 113
2022
Q3 		$8.97M Sell
17,692
-9,031
-34% -$5.05M 0.14% 82
2022
Q2 		$14.5M Sell
26,723
-2,480
-8% -$1.37M 0.32% 60
2022
Q1 		$17.2M Sell
29,203
-16,452
-36% -$9.45M 0.23% 62
2021
Q4 		$30.5M Sell
45,655
-63,304
-58% -$39.5M 0.52% 27
2021
Q3 		$62.3M Buy
108,959
+36,640
+51% +$20.1M 0.94% 15
2021
Q2 		$36.5M Buy
72,319
+23,878
+49% +$11.3M 0.51% 28
2021
Q1 		$22.1M Sell
48,441
-22,743
-32% -$10.9M 0.5% 27
2020
Q4 		$33.2M Buy
71,184
+11,494
+19% +$5.39M 2.28% 12
2020
Q3 		$26.4M Sell
59,690
-50,113
-46% -$20.7M 2.81% 9
2020
Q2 		$39.8M Buy
+109,803
New +$36.8M 3.38% 8
2020
Q1 		– Sell
-23,511
Closed -$7.64M – 165
2019
Q4 		$7.64M Sell
23,511
-25,093
-52% -$7.61M 0.81% 35
2019
Q3 		$14.2M Sell
48,604
-74,121
-60% -$21.2M 1.59% 18
2019
Q2 		$36M Sell
122,725
-26,614
-18% -$7.33M 4.01% 7
2019
Q1 		$40.9M Buy
149,339
+69,259
+86% +$17.2M 4.31% 5
2018
Q4 		$17.9M Buy
+80,080
New +$18.8M 2.22% 16

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Waratah Capital Advisors's TMO Position: Q3 2025 in Review

Waratah Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 7,266 shares — an estimated $2.95M sold.

Waratah Capital Advisors first reported a position in TMO in Q4 2018 and held it in 26 quarters. The position peaked at $62.3M in Q3 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Waratah Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Waratah Capital Advisors sold 7,266 Thermo Fisher Scientific shares in Q3 2025, an estimated $2.95M.
  • Waratah Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 26 quarters.
  • Waratah Capital Advisors's Thermo Fisher Scientific position peaked at $62.3M in Q3 2021.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Waratah Capital Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.